Acute Rhinosinusitis Clinical Trial
Official title:
Efficacy and Safety of 200 mcg QD or 200 mcg BID Mometasone Furoate Nasal Spray (MFNS) vs Amoxicillin vs Placebo as Primary Treatment of Subjects With Acute Rhinosinusitis
This study was conducted to compare the effectiveness and safety of mometasone nasal spray once daily or twice daily with amoxicillin or with placebo in treating the signs and symptoms of acute rhinosinusitis. Patients received mometasone nasal spray 2 sprays per nostril once daily, 2 sprays per nostril twice daily, amoxicillin 500 mg three times a day, or placebo three times a day. Patients on nasal spray were treated for 15 days and patients on amoxicillin or placebo were treated for 10 days. All patients were followed-up with a 14-day no-treatment observation period.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04131686 -
NAC Inhalation in the Treatment Of Symptomatic acuTe rhinosinUSitis
|
||
Not yet recruiting |
NCT03517215 -
The Development and Testing of a Scaling Strategy for a Community-Based Primary Care Antimicrobial Stewardship Program
|
N/A | |
Completed |
NCT05639959 -
Efficacy and Safety of New Mometasone Furoate Nasal Spray Formulation in Acute Rhinosinusitis Patients: A Randomized Clinical Trial
|
||
Completed |
NCT00377403 -
Treatment of Acute Sinusitis
|
Phase 4 | |
Completed |
NCT03693976 -
Non-interventional Study With Ectoin Containing and/or Decongesting Nasal Spray in Patients With Rhinosinusitis
|
||
Completed |
NCT03480100 -
Non-interventional Study of Ectoin Nasal Douche (END01) in Patients With Acute Viral Rhinosinusitis
|
||
Completed |
NCT02296814 -
Efficacy and Safety of Sinusitis Hevert SL Tablets Compared to Placebo in Adult Patients With Acute, Uncomplicated Rhinosinusitis
|
Phase 4 | |
Completed |
NCT01553110 -
An Observational Study to Evaluate The Relationship of Nasal Mucus Properties and Symptoms
|
||
Completed |
NCT01691677 -
beCLomethasone Efficacy in Acute Rhinosinusitis - CLEAR Study
|
Phase 3 | |
Completed |
NCT01146860 -
Efficacy and Safety of a Herbal Medicinal Product (Dry Extract BNO 1016) in Patients With Acute Rhinosinusitis
|
Phase 3 | |
Completed |
NCT00750750 -
Effectiveness and Safety of Once or Twice Daily Mometasone Nasal Spray Versus Amoxicillin Versus Placebo for Treatment of Acute Rhinosinusitis (Study P02683)
|
Phase 2 |